mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.02 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |